AAS
NVCR icon

Ameritas Advisory Services’s NovoCure NVCR Stock Holding History

Ameritas Advisory Services’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-100
Closed -$6.32K – 1876
2023
Q1 		$6.32K Buy
+100
New +$7.99K ﹤0.01% 2079

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return

Ameritas Advisory Services's NVCR Position: Q2 2023 in Review

Ameritas Advisory Services sold out of NovoCure (NVCR) in Q2 2023, closing a stake of 100 shares — an estimated $6.32K sold.

Ameritas Advisory Services first reported a position in NVCR in Q1 2023 and held it in 1 quarter. The position peaked at $6.32K in Q1 2023. 267 funds tracked by Wall St. Rank hold NVCR as of Q2 2023.

  • Ameritas Advisory Services reported no remaining NovoCure position as of Q2 2023 after selling out during the quarter.
  • Ameritas Advisory Services sold 100 NovoCure shares in Q2 2023, an estimated $6.32K.
  • Ameritas Advisory Services first reported a position in NovoCure in Q1 2023 and held it in 1 quarter.
  • Ameritas Advisory Services's NovoCure position peaked at $6.32K in Q1 2023.
  • 267 funds tracked by Wall St. Rank held NovoCure as of Q2 2023.

Based on Ameritas Advisory Services's 13F filing for Q2 2023, filed 25 Jul 2023.